dihexa approval status fda Peptide What if neuroplasticity research targeted

Circ Res 116:15611578 Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I et al (1997) Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats

Their conclusion echoes what others have found when they've looked at the body of evidence for these therapies

This comprehensive PK and tissue distribution datasetthe first of its kindinforms clinical trial design and underscores the systemic therapeutic potential of BPC157

The preclinical and animal studies indicate benefits for tendon and joint injuries, says Drew Timmermans, ND, a naturopathic physician and cofounder of Regenerative Performance in Arizona